Filing Details

Accession Number:
0000899243-23-017445
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-07-19 16:05:10
Reporting Period:
2023-07-12
Accepted Time:
2023-07-19 16:05:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Aceragen Inc. ACGN Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193366 El Youssef Zein C/O Stuarts Corporate Services Ltd.
Kensington House, 69 Dr. Roy'S Drive
Georgetown, Grand Cayman E9 KY1-1104
No No Yes No
1534428 Pillar Invest Corp C/O Stuarts Corporate Services Ltd.
Kensington House, 69 Dr. Roy'S Drive
Georgetown, Grand Cayman E9 KY1-1104
No No Yes No
1783582 Abude Umari C/O Stuarts Corporate Services Ltd.
Kensington House, 69 Dr. Roy'S Drive
Georgetown, Grand Cayman E9 KY1-1104
No No Yes No
1783583 Pillar Partners Foundation, L.p. C/O Stuarts Corporate Services Ltd.
Kensington House, 69 Dr. Roy'S Drive
Georgetown, Grand Cayman E9 KY1-1104
No No Yes No
1783584 Pillar Pharmaceuticals 6, L.p. C/O Stuarts Corporate Services Ltd.
Kensington House, 69 Dr. Roy'S Drive
Georgetown, Grand Cayman E9 KY1-1104
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-07-12 3,605 $1.58 167,107 No 4 S Indirect By Abude UmariSee Footnote
Common Stock Disposition 2023-07-13 2,213 $1.54 164,894 No 4 S Indirect By Abude UmariSee Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Abude UmariSee Footnote
No 4 S Indirect By Abude UmariSee Footnote
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 355,247 Indirect By Pillar Partners Foundation, L.P. See Footnote
Common Stock 135,540 Indirect By Pillar Pharmaceuticals 6, L.P. See Footnote
Common Stock 1,547 Indirect By Youssef El Zein See Footnote
Footnotes
  1. Pillar Invest Corporation ("Pillar GP") is the general partner of Pillar Pharmaceuticals 6, L.P. ("Pillar 6") and Pillar Partners Foundation, L.P. ("Pillar Partners", together with Pillar GP and Pillar 6, the "Pillar Funds"). Youssef El Zein and Abude Umari are directors of Pillar GP. Each of Pillar GP, Mr. El Zein and Mr. Umari disclaims Section 16 beneficial ownership of the securities beneficially owned by the Pillar Funds and this report shall not be deemed an admission that any of Pillar GP, Mr. El Zein or Mr. Umari is the Section 16 beneficial owner of any such securities, except to the extent of its or his pecuniary interest therein, if any, by virtue of its or his ownership interest in the Pillar Funds or Pillar GP, as applicable.